Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Baxter
Express Scripts
Merck
McKinsey

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019604

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 019604 describes VOLMAX, which is a drug marketed by Muro and is included in one NDA. Additional details are available on the VOLMAX profile page.

The generic ingredient in VOLMAX is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
Summary for 019604
Tradename:VOLMAX
Applicant:Muro
Ingredient:albuterol sulfate
Patents:0
Formulation / Manufacturing:see details
Paragraph IV (Patent) Challenges for 019604
Tradename Dosage Ingredient NDA Submissiondate
VOLMAX TABLET, EXTENDED RELEASE;ORAL albuterol sulfate 019604

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 8MG BASE
Approval Date:Dec 23, 1992TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 4MG BASE
Approval Date:Dec 23, 1992TE:RLD:No

Expired US Patents for NDA 019604

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992   Start Trial   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-002 Dec 23, 1992   Start Trial   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-002 Dec 23, 1992   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Merck
Mallinckrodt
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.